View Article

  • Quality Risk Management in Pharmaceutical Industry: A Review

  • Department of Pharmacy, JES's SND College of Pharmacy, Babulgaon (Yeola), India

Abstract

This piece intends to outline the foundational principles and practical examples of Quality Risk Management (QRM) tools applicable across various facets of pharmaceutical quality assurance. These facets encompass development, production, distribution, inspection, and the submission of review processes throughout the drug substance, product, and biological product lifecycles. Quality Risk Management represents a comprehensive and ongoing endeavour to reduce risks to product quality throughout its lifecycle, aiming to maximize its benefits while maintaining a risk benefit balance. It is a structured approach for assessing, managing, communicating, and reviewing risks to the product's quality. The core QRM process should encompass the required effort, formalities, and documentation that align with the risk level. The principles of Quality Risk Management are effectively applied in numerous sectors, including business, government, insurance, workplace safety, public health, pharmacovigilance, and regulatory oversight. The risk assessment process involves analysing, identifying, and evaluating risks, followed by the review of QRM strategies.

Keywords

Quality management system, Total quality management, WHO, ICH, quality by design

Introduction

life cycle, quality risk management (QRM) is a Quality Risk Management comprehensive and ongoing (QRM) has been a mandated process that aims to minimize regulatory obligation for risks to the product's quality while healthcare businesses for the past balancing the associated hazards. few years (1). Throughout a product's It follows a methodical procedure for identifying, managing, sharing, and reviewing risks to the pharmaceutical product's quality. It supports science based and practical decisions when integrated into quality systems, examples of quality systems include Validation, Quality Defects- Investigation, Auditing, Inspection, Documentation, Training etc.(1) Quality Risk Management principles are effectively utilized in many areas including business, insurance, work related safety, public health, pharmacovigilance, and by agencies regulating these industries (2). Even though there are some examples of the use of quality risk management in the pharmaceutical industry, today they are limited and do not represent the full contributions that risk management has to offer. In relation to pharmaceuticals, though there are a variety of stakeholders, including medical practitioners and patients as well as government and industry, the safety of the patient by managing the risk to quality should be considered prime importance. The manufacturing and use of a drug product, including its components, necessarily involve some degree of risk. Use of QRM can ameliorate the decision making If quality problem arises.(3)

2.Defining Risk:   

Preliminary working definitions from ICH EWG on QRM Q9:  

Risk :- Combination  of  the  probability  of  occurrence  of  Harm and the severity of that harm. ISO 14971. 

Harm :-Damage to health, including the damage that can occur from loss of product efficacy, safety, Quality or availability.  

Quality:-Degree to which a set of inherent characteristics of a product, system or process fulfils requirements.  

Requirements :- Needs or expectations that  is stated, generally implied  or  obligatory  by  the patients or  their  Surrogates (e.g.  health care professionals, regulators and legislators). 

Combining key terms :-  Risk  to quality is the  probability/severity   that   drug will   fail   to   meet   the  needs/expectations of  the  patients  and  their  surrogates.(4)

  1. Quality Risk Management:

English Quality risk management has become an important issue in quality management in many manufacturing functions. It is a project management tool and a key element of quality by design. ICH Q9 introduced quality risk management (QRM) guidelines which were adopted in November 2005 (Vesper and O Donnell, 2016). However, Donnell and Greene (2007) developed a practical QRM approach to facilitate compliance with EU Good Manufacturing Practice (GMP) requirements and the ICH Q9 guideline. The researcher called for further efforts to promote the continued development of environmental QRM (GMP) methods and approaches to minimize and manage risks posed by medicines to patients. In 2008, Frank et al. (4) (2011) demonstrates the efforts of the Risk Management Working Group in assembling industry case studies aimed at improving the understanding and application of ICH Q9, including n of eight industry representatives and the US FDA. They demonstrate the need to select the appropriate risk methodology for the target need, taking into account the complexity and risks associated with the specific issue and the importance of predetermining the potential risk classification so as not to be influenced by the outcome of the assessment when determining the appropriate response.2013, practical means for analyzing quality risks. machine had been defined through Lotllikar MV who supplied guidance long side the manner to acquire powerful nice control and compliance thru QRM, the paper concluded that when making use of chance control to pharmaceutical enterprise it will lessen the quantity of threats or reduce their effect the constant use of the tools/techniques and periodic review, the output of the chance control helps the corporation to meet the described dreams closer to safety of public health (Lotllikar, 2013) (4). As Muhammad and Rehana (2014) proved that QRM improves chance consciousness and hastens detection of potential problems the usage of nice statistics to control product nice, production tactics and compliance inside a chance primarily based totally Quality Management System, the very last item will make certain the excessive nice of the drug product to the patient .According to Haleem et al. (2015), chance Management is a vital nice subjects won the unique difficulty in chemical and pharmaceutical nice assurance, they invited each managers on the pharmaceutical enterprise and  literature to recognition at the adoption of practices like lean production, Six Sigma and overall nice control into the pharmaceutical enterprise to reduce the opportunity of QRM. Kumar and Jha (2018) admitted that there are instances of unresolved client court cases and batch disasters originated due to inadequacies all through distribution of pharmaceutical Products, they added a version to lessen the product rejection the usage of Risk.    

Reference

  1. Kevin O’Donnell, Deirdre Tobin, Stephanie Butler, Ghada Haddad, Donal Kelleher, ‘Understanding the concept of formality in quality risk management’, Technological university       Dublin. Volume 15 | Issue 2 Article 15.  Page.No :1-5.
  2. ICH guideline Q9 on Quality Risk Management, European Medicine Agencies, Page. No: 3-6
  3. ICH Harmonised Tripartithe Guideline ‘Quality Risk Management Q9’ Current step 4 version dated 9 November 2005. Page No: 7-9 
  4. Madhavi E. Kadam, Prof. Dhwani Bhavsar, ‘A Review Of Total Quality Management In Pharmaceutical Industries’, International journal of creative research thoughts [IJCRT]. Volume 10, Issue 3 march 2022. Page No: 2-5
  5. Abdul Sattar Khan, Fauziya Khan and Nutan Rao, ‘Quality Risk Management in Pharmaceutical Industry’, International Journal of Research in Pharmacy and Chemistry [IJRPC] Issue 10.2.2022. Page No: 215- 218
  6. Guidance for Industry Q10 Pharmaceutical Quality System, U.S Department of health and human services food and drug administration, Center for drug and evaluation and research [CDER], center for biologics evaluation and research [CBER]. April 2009 ICH.  Page No: 5-8.   
  7. Sachin L. Darkunde, Department of Quality Assurance, ‘A Review by Quality by Design’.2018. Page No: 2-6
  8. Assessment of quality risk management implementation, 1 january 2001. Page No: 1-9
  9. Omar A. ISMAEL, Moyassar I. AHMED, Using Quality Risk Management in Pharmaceutical Industries: A Case Study. Volume 21, No. 178/October 2020. Page No: 2-8
  10. Rawidh Alsaidalani, Bassam Elamdhoun , Quality Risk Management in Pharmaceutical Supply Chain, Warehousing and Dispensing -  Practical Case Study from Sterile Pharmaceutical Industry: A Research Article. May-June 2021, Article No. 23, Page. No :155- 163
  11. N. Vishal Gupta, Quality Risk Management in Pharmaceutical Industry: A Review, International Journal of PharmaTech research January 2014. Page. No: 911- 914
  12. V Vijaykumar Reddy, N Vishal Gupta, H V Raghunandan , U Nitin Kashyap , ‘Quality Risk Management in Pharmaceutical Industry:  A review, International Journal of PharmaTech Research. Volume. 6, No. 03, Page.No : 38-53 
  13. Meenu Chaudhary, Priya, Hazards Analysisand Critical Control Points as a Quality Risk Management Tool in the Pharmaceutical Industry: A Systematic Review, Journal Of Drug Delivery and Therapeutics. Issue – 15 Oct 2021. Page. No: 167-172
  14. Huma Ali, and Rajesh Hajela , Risk assessment and management in pharmaceutical industries: Vital requirement to ensure product quality ,Issue. Date: 21 april 2011, Page no: 1-2
  15. T. Frank, S. Brooks, R. Creekmore, B. Hasselbalch , K. Murray , K. Obeng , S. Reich , E. Sanchez . Quality Risk Management Principles and Industry Case Studies, Issue. Date: 28 Dec 2008. Page. No: 2-6
  16. Lorely MILA Caceres et al. Quality Risk Management Application in Pharmaceutical and Biopharmaceutical Industries, Bioprocessing Journal. Page. No:  29-34
  17. Lotlikar MV, Quality Risk Management: A Review, Journal of Drug Delivery & therapeutics; 2013, 3(2), Page. No:  152-154
  18. Rawidh Alsaidalani, and Bassam Elmadhoun , Quality Risk Management in Pharmaceutical Manufacturing Operations : Case Study For Sterile Product Filling and Final Product Handling Stage. Page. No: 4 -13

Photo
Priya Wagh
Corresponding author

Department of Pharmacy, JES's SND College of Pharmacy, Babulgaon (Yeola), India

Photo
Ramdas Darade
Co-author

Department of Pharmacy, JES's SND College of Pharmacy, Babulgaon (Yeola), India

Priya Wagh*, Ramdas Darade, Quality Risk Management in Pharmaceutical Industry: A Review, Int. J. Sci. R. Tech., 2025, 2 (3), 528-533. https://doi.org/10.5281/zenodo.15091362

More related articles
Design Optimization of a Mini Belt Grinding Machin...
S. Arunachalam, U. Gokulnath, M. Kathiravan, S. Dhanush, G. Kaviy...
A Comprehensive Review on Pharmacological Activity...
Muskan Gandhi, Hitesh Kumarkhaniya, Bharat Maitreya , ...
Synergistic Combinations Of Natural Antifungals ...
Praveen Sahu, Nishika Tamrakar, Ramya Sri, Suchita Wamankar, Gyan...
Validated Analytical Approaches for Sitagliptin Monohydrate and Metformin: A Cri...
Manda Sreekanth, Konda Sri Vaishnavi, Padugula Soumya, Nenavath Kanakaraju, Tadikonda Rama Rao, ...
Ion Exchange Chromatography in the Analysis of Brain-Derived DNA: Unravelling th...
Arnab Roy, Mahesh Kumar Yadav, Ashish Kumar, Rishu Raj , ...
Related Articles
Overview Of Long-Acting Injectable Schizophrenia Medications...
Pruthviraj Awate, Bhagyashri Randhawan, Naman Gandhi, Harish Changediya, Komal Dhakane, ...
Insilico Studies and Synthesis of New 2-Cycloproply Quinazoline Derivatives as P...
Soheila Azim Patrawala, Dr. Bhavini Gharia, Amankumar Vaghasiya, ...
Abdominal DSCT Effectiveness of Contrast Media Dose on Basis of BMI...
Virendra Kumar Maurya, Neha Gupta, Rahul Gangwar, Priyanka Saxena, Richa Mishra, Ravi Kumar, ...
Design Optimization of a Mini Belt Grinding Machine for High-Accuracy Lathe Tool...
S. Arunachalam, U. Gokulnath, M. Kathiravan, S. Dhanush, G. Kaviyarasu, ...
More related articles
Design Optimization of a Mini Belt Grinding Machine for High-Accuracy Lathe Tool...
S. Arunachalam, U. Gokulnath, M. Kathiravan, S. Dhanush, G. Kaviyarasu, ...
A Comprehensive Review on Pharmacological Activity and Secondary Metabolites of ...
Muskan Gandhi, Hitesh Kumarkhaniya, Bharat Maitreya , ...
Synergistic Combinations Of Natural Antifungals In The Management Of Dermatoph...
Praveen Sahu, Nishika Tamrakar, Ramya Sri, Suchita Wamankar, Gyanesh Sahu, Chanchal Kaur, ...
Design Optimization of a Mini Belt Grinding Machine for High-Accuracy Lathe Tool...
S. Arunachalam, U. Gokulnath, M. Kathiravan, S. Dhanush, G. Kaviyarasu, ...
A Comprehensive Review on Pharmacological Activity and Secondary Metabolites of ...
Muskan Gandhi, Hitesh Kumarkhaniya, Bharat Maitreya , ...
Synergistic Combinations Of Natural Antifungals In The Management Of Dermatoph...
Praveen Sahu, Nishika Tamrakar, Ramya Sri, Suchita Wamankar, Gyanesh Sahu, Chanchal Kaur, ...